Post Herpetic Neuralgia
About the Case Study
To successfully complete a Phase II Post Herpetic Neuralgia (PHN) study, Allucent was contracted to provide a full-service solution to support 103 patients from 27 sites in four countries. In the past, study sponsors have had difficulty recruiting patients in Post Herpetic Neuralgia studies, but due to prior experience with these studies and a proactive approach, Allucent recruited the required number of patients seven weeks prior to the sponsors’ deadline.
- Phase: II
- Patients: 103
- Sites: 27 in 4 countries - South Africa, Bulgaria, Georgia, and Ukraine
- Services Provided: Regulatory, Monitoring, Project Management, Medical Writing, Data Management, Statistics, Pharmacovigilance, Medical Monitoring, DSMB Management